SR-878

· SciRhom GmbH

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SR-878, covering 2025-06-03 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis [Phase 1]